Cardiovascular Surgery

This channel includes news and new technology innovations for cardiac surgery. This includes coronary artery bypass grafts (CABG) and surgical valve replacements.

Societies Issue Guide to Safely Resume Cardiovascular Procedures, Diagnostic Tests. #COVID19 #SARScov2

Feature | Cardiovascular Business

Societies Issue Guide to Safely Resume Cardiovascular Procedures and Tests

The American College of Cardiology (ACC) together with other North American cardiovascular societies issued a framework ...

June 03, 2020

News | Artificial Heart

First Implantation of Carmat Total Artificial Heart in Denmark

May 27, 2020 — Carmat, a developer of the of a next generation advanced total artificial heart, announces the first ...

May 27, 2020

News | ECMO Systems

Abiomed Adds ECMO Cardiopulmonary Support to its Portfolio

May 1, 2020 — Abiomed, maker of the Impella heart pump, has acquired Breethe, developer of a novel extracorporeal ...

May 01, 2020

News | Coronavirus (COVID-19)

LivaNova Modifies its ECMO Indications Beyond Six Hours to Address COVID-19

April 23, 2020 – LivaNova PLC said the U.S. Food and Drug Administration (FDA) is now permitting the company to expand ...

April 23, 2020

An ECMO cannula being inserted into a cardiovascular patient in need of mechanical oxygenation and hemodynamic support in December 2019. The FDA just made a temporary approval to use ECMO support in COVID-19 patients during the pandemic emergency. #COVID19 #SARScov2 #coronavirus

Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

FDA Approves ECMO to Treat COVID-19 Patients

April 7, 2020 — The U.S. Food and Drug Administration (FDA) has issued guidance to provide a policy to help expand the ...

April 07, 2020

Closing access to the radial artery after harvesting a section of the artery for a coronary artery bypass graft (CABG). Photo by Getty Images. #ACC20 #ACC2020

News | Cardiovascular Surgery

Radial Artery Versus Saphenous Vein For Coronary Bypass Surgery Long Term Follow-up

March 30, 2020 — Patients undergoing coronary bypass graft (CAGB) surgery lived longer and had better outcomes when ...

March 30, 2020

Conclusions from the TAVR vs surgery trial for aortic valve replacement in the U.K. presented by William D. Toff, M.D. at ACC 20. #ACC20 #ACC2020 #TAVR #TAVR

News | Heart Valve Technology

TAVR Non-Inferior to Surgery in U.K. Review of Surgery vs. TAVR

March 30, 2020 — Patients in the United Kingdom (U.K.) who underwent transcatheter aortic valve replacement (TAVR) did ...

March 30, 2020

PARTNER 3 trial shows positive results for Sapien 3 in low-risk surgical patients. #ACC20 #ACC2020 #Sapien3 #TAVR

Feature | Heart Valve Technology

TAVR Equivalent to Surgery at Two Years in Low-Risk Patients

March 30, 2020 — Low-risk patients undergoing transcatheter aortic valve repair (TAVR) at two years did just as well ...

March 30, 2020

News | Heart Valve Technology

U.S. TAVR Outcomes Need Improvement Based on TVT Registry Analysis

March 29, 2020 — Worse than expected outcomes were found for survival and quality of life among patients undergoing ...

March 29, 2020

Patients with bicuspid, or two-leaflet, aortic valves who undergo transcatheter aortic valve replacement (TAVR) procedures had a high rate of success and low risk of death or disabling stroke at 30 days, according to new data presented at the American College of Cardiology (ACC) 2020 Scientific Session. #ACC20 #ACC2020

Feature | Heart Valve Technology | Dave Fornell, Editor

TAVR Shows Favorable Safety in Patients with Bicuspid Valve

March 29, 2020 — Patients with bicuspid, or two-leaflet, aortic valves who undergo transcatheter aortic valve ...

March 29, 2020

Medicare, CMS, calls for cancelling or postponing all elective or non-essential medical procedures, test and surgeries due to COVID-19. #COVID19 #SARcov2 #coronavirus #cardiology

Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

CMS Calls For Postponing All Elective Cardiac Tests and Procedures to Aid COVID-19 Containment

March 20, 2020 — The Centers for Medicare and Medicaid Services (CMS) announced March 18, 2020, that all elective ...

March 20, 2020

Videos | Coronavirus (COVID-19)

VIDEO: Cancelling Non-essential Cardiac Procedures During the COVID-19 Outbreak

An interview with Ehtisham Mahmud, M.D., FSCAI, chief, Division of Cardiovascular Medicine, executive director of ...

March 20, 2020

News | Artificial Heart

FDA Clears SynCardia 50cc Temporary Total Artificial Heart as Bridge to Transplant

March 10, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the SynCardia Systems 50cc temporary Total ...

March 10, 2020

ACC issues document outlining COVID-19 Implications For Patients With Underlying Cardiovascular Conditions. The COVID-19 mortality rate for patients cardiovascular disease is 10.5 percent based of data from Chinese hospitals since the outbreak. COVID-19 fatality rates for patients with comorbidities are higher than the average population, but cardiac patients had the highest death rate. #COVID19 #coronavirus #2019nCoV #SARS‐CoV‐2

Feature | Coronavirus (COVID-19)

ACC COVID-19 Clinical Guidance For the Cardiovascular Care Team

March 9, 2020 — The American College of Cardiology (ACC) is offering updates on the clinical impact of novel coronavirus ...

March 09, 2020

News | Heart Failure

Abbott’s In-Development Fully Implantable Heart Pump System Earns FDA’s Breakthrough Device Designation

March 5, 2020 — Abbott recently received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA ...

March 05, 2020